Wells Fargo Lowers Price Target for Colgate-Palmolive Despite Maintaining "Underweight" Rating
ByAinvest
Friday, Sep 26, 2025 8:46 pm ET1min read
CL--
This latest move follows a series of price target reductions by various analysts in recent months. On August 4, 2025, Wells Fargo had already lowered the price target from $88.00 to $83.00, and other major analysts like Morgan Stanley, JP Morgan, and Citigroup have also adjusted their price targets, indicating a cautious approach to the company's stock [2].
Colgate-Palmolive, founded in 1806, is a leading player in the household and personal care industry. It manufactures a wide range of products, including oral care, shampoos, shower gels, deodorants, and home care products, sold in over 200 countries. International sales account for approximately 70% of its total business, with a significant portion coming from emerging regions. The company also owns Hill's, a specialty pet food maker, which generates around one-fifth of its sales [2].
Analysts' forecasts indicate a mixed sentiment. Based on one-year price targets from 19 analysts, the average target price is $94.75, with a high estimate of $106.00 and a low estimate of $79.00. This average target implies an upside of 16.47% from the current price of $81.35 [2]. The consensus recommendation from 21 brokerage firms is "Outperform," indicating a positive outlook despite the recent price target reductions [2].
Investors are advised to consider these ratings and forecasts when making investment decisions. The ongoing evaluations by analysts suggest a cautious approach to Colgate-Palmolive's stock, reflecting a potential shift in market sentiment.
WFC--
Wells Fargo maintains "Underweight" rating for Colgate-Palmolive and lowers price target to $80.00 from $83.00. The adjustment reflects ongoing evaluations by analysts regarding Colgate-Palmolive's market positioning and financial outlook. Investors are advised to consider these ratings when making investment decisions.
Wells Fargo has maintained its "Underweight" rating for Colgate-Palmolive (NYSE: CL) but has lowered the price target from $83.00 to $80.00, reflecting ongoing evaluations of the company's market positioning and financial outlook. The adjustment was made by Wells Fargo analyst Chris Carey on September 25, 2025 [1].This latest move follows a series of price target reductions by various analysts in recent months. On August 4, 2025, Wells Fargo had already lowered the price target from $88.00 to $83.00, and other major analysts like Morgan Stanley, JP Morgan, and Citigroup have also adjusted their price targets, indicating a cautious approach to the company's stock [2].
Colgate-Palmolive, founded in 1806, is a leading player in the household and personal care industry. It manufactures a wide range of products, including oral care, shampoos, shower gels, deodorants, and home care products, sold in over 200 countries. International sales account for approximately 70% of its total business, with a significant portion coming from emerging regions. The company also owns Hill's, a specialty pet food maker, which generates around one-fifth of its sales [2].
Analysts' forecasts indicate a mixed sentiment. Based on one-year price targets from 19 analysts, the average target price is $94.75, with a high estimate of $106.00 and a low estimate of $79.00. This average target implies an upside of 16.47% from the current price of $81.35 [2]. The consensus recommendation from 21 brokerage firms is "Outperform," indicating a positive outlook despite the recent price target reductions [2].
Investors are advised to consider these ratings and forecasts when making investment decisions. The ongoing evaluations by analysts suggest a cautious approach to Colgate-Palmolive's stock, reflecting a potential shift in market sentiment.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet